Premium
Cytoreductive procedures—strategies to reduce postoperative morbidity and management of surgical complications with special emphasis on anastomotic leaks
Author(s) -
Jaehne Joachim
Publication year - 2009
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21328
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , cytoreductive surgery , surgery , peritoneal carcinomatosis , anastomosis , blood loss , general surgery , cancer , colorectal cancer , ovarian cancer
Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for the therapy of peritoneal carcinomatosis are associated with substantial morbidity and acceptable mortality. Patient selection, learning curve, patient warming, and reduced blood loss are the main factors to decrease morbidity. Morbidity is mostly associated with bowl fistulas and anastomotic leakages. Depending on the site of leaks they may be managed conservatively or by reoperation. For standardization of study reports on morbidity and mortality the CTCAE classification is recommended. J. Surg. Oncol. 2009;100:302–305. © 2009 Wiley‐Liss, Inc.